Off-label use of drugs in Italy: a prospective, observational and multicentre study

被引:61
|
作者
Pandolfini, C [1 ]
Impicciatore, P [1 ]
Provasi, D [1 ]
Rocchi, F [1 ]
Campi, R [1 ]
Bonati, M [1 ]
机构
[1] Mario Negri Inst Pharmacol Res, Lab Mother & Child Hlth, IT-20157 Milan, Italy
关键词
children; drug labelling; Italy; multicentre study; off-label drug use;
D O I
10.1080/08035250252834030
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The aims of the study were to measure the paediatric, off-label use of drugs in the Italian hospital setting and to reveal areas for priority intervention by investigating the therapeutic indications most involved. Prescriptions given to all children admitted to nine general paediatric hospital wards from December 1998 to February 1999 were analysed. In total, 4265 prescriptions were given to 1461 children, 10 of which were unlicensed and excluded from further analysis. Sixty percent of prescriptions (range between centres: 44-71%) were off-label and concerned 89% of children receiving medications (80-96%). The main drug classes were antibacterials, antiasthmatics and analgesics, and represented 56% of off-label prescriptions. Paracetamol (385 prescriptions) and beclomethasone (339) were the generic substances most often used off-label. The most common off-label categories were dosage/frequency (50% of prescriptions), indication and lack of paediatric licence (7% each). Fifty-four per cent 4 all indications that led to off-label prescribing involved only respiratory problems. fever, respiratory tract infections and bronchospasm. Conclusion: Despite prescription profile differences among centres, off-label use was high everywhere. Immediate action for more rational drug use is necessary and requires not only regulatory intervention but also a more evidence-based, therapeutic approach.
引用
收藏
页码:339 / 347
页数:9
相关论文
共 50 条
  • [21] Use of off-label anti tumour drugs
    Viano, Ilario
    [J]. FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2007, 8 : 15 - 18
  • [22] The peculiarities of off-label use of drugs in pediatrics
    Drohovoz, S. M.
    Butko, Ya O.
    Ivantsyk, L. B.
    Shchokina, C. H.
    Bielik, H., V
    Lukianchuk, V. D.
    [J]. ZAPOROZHYE MEDICAL JOURNAL, 2020, 22 (05) : 714 - 718
  • [23] Off-label use of drugs in psychiatry and neurology
    Wallesch, CW
    [J]. FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2004, 72 (05) : 243 - 244
  • [24] Tackling Off-Label Use of Anticancer Drugs
    Perrone, Francesco
    de Braud, Filippo
    Labianca, Roberto
    Tomino, Carlo
    Roila, Fausto
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (22) : 2800 - 2800
  • [25] Off-label use of drugs - the legal framework
    Koyuncu, A.
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (30) : 1519 - 1523
  • [26] Off-label use of drugs: An evil or a necessity?
    Gota, Vikram
    Divatia, Jigeeshu V.
    [J]. INDIAN JOURNAL OF ANAESTHESIA, 2015, 59 (12) : 767 - 768
  • [27] Off-Label Use of Alzheimer's Drugs
    Vivian, Jesse C.
    [J]. US PHARMACIST, 2012, 37 (03) : 61 - 63
  • [28] Chinese Regulation of Off-label Use of Drugs
    Ma, Feng
    Lou, Nan
    [J]. FOOD AND DRUG LAW JOURNAL, 2013, 68 (02) : 189 - 200
  • [29] Administration of label and off-label drugs by the subcutaneous route in palliative care: an observational cohort study
    Jensen, Jesper Jorgen
    Sjogren, Per
    [J]. BMJ SUPPORTIVE & PALLIATIVE CARE, 2022, 12 (E6) : E723 - E729
  • [30] Off-Label Medicine Use in Pediatric Inpatients: A Prospective Observational Study at a Tertiary Care Hospital in India
    Saiyed, Mohd Masnoon
    Lalwani, Tarachand
    Rana, Devang
    [J]. INTERNATIONAL JOURNAL OF PEDIATRICS, 2014, 2014